Research
Cellular
Endoluminal metabolic and bariatric therapy may be an appealing option for patients ineligible for or averse to bariatric surgery.
Practitioners should consider these therapies for patients who cannot or do not want to undergo traditional surgery.
StrongSupportsmedium confidence
By virtue of its minimally invasive approach, this therapy may be an appealing option for patients who are ineligible for, or averse to, bariatric surgery.
Why this rating
The abstract discusses the potential benefits of these therapies for specific patient groups.
Source
Endoluminal bariatric and metabolic therapies: state-of-the-art
Nader Bakheet et al. · Current Opinion in Gastroenterology · 2023
DOI 10.1097/mog.0000000000000967
reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Endoluminal bariatric and metabolic therapies have expanded significantly, with FDA-approved therapies available for patients with a body mass index as high as 50 kg/m².Strong
- Endoluminal interventions should be combined with a moderately intensive diet and lifestyle program lasting at least 12 months for optimal results.Strong
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →